Andreas G Weichert
Andreas G Weichert
Pharmaceutical R&D Expert
Hamburg Area, Germany | Pharmaceuticals
312 Patents

Updating LinkedIn profile...

Please don't close this dialog or refresh the page.


Current
  • Principal & Owner at Dr. Weichert - Life Sciences Consulting
Past
  • Associate Director & Research Advisor at Eli Lilly
  • Principal Research Scientist at Lilly Research Laboratories
  • Research Scientist at Hoechst AG, Hoechst Marion Roussel, Aventis
Education
  • Universität Hannover / University of Hanover (PhD)
  • Universität Hannover / University of Hanover (Dipl.-Chem.)

Entrepreneurial executive with broad expertise in project- and innovation management as well as business development. Longtime management and leadership responsibilities in Big Pharma companies, multicultural working experience (EU, USA, Asia). Collaborations with MedTech companies, CROs and non-profit organizations. About 20 years of pharmaceutical experience and deep pharmaceutical industry knowledge, combined with a strong technical background; more than 50 granted US patents and 25 manuscripts.

Specialties

Identification of value creating opportunities related to healthcare based on preclinical R&D at the interfaces of Pharma, Medtech and Nanotech. Medicinal Chemistry, compound library design, lead generation, lead optimization, drug discovery & delivery, biodegradable materials, controlled drug release, drug eluting coatings, combination devices.

Experience

Principal & Owner
Dr. Weichert - Life Sciences Consulting

July 2007 - present (7 years)
Founded independent project management and business development firm specializing in value creation tied to cross-industrial innovation experience, market expertise and expert partner network: - Preclinical strategic and technical R&D consulting - ID of technology/service provider, management of feasibility studies and IP generation - Assessment of clients’ technology and IP assets for partnering/sales process - New business development in Europe for international Pharma CROs
Associate Director & Research Advisor
Eli Lilly

May 2003 - June 2007 (4 years 2 months)
- Accountable for local discovery chemistry department and portfolio deliverables - Managed department staff and held full budget responsibility - Implemented new lead generation paradigm which led to improved productivity - Contributed to global management team and local site lead team decisions - Influenced scientific R&D review and governance teams in all major therapeutic areas - Involved in global resource allocation and people management measures - Represented global function in technical due-diligence activities
Principal Research Scientist
Lilly Research Laboratories

January 2001 - April 2003 (2 years 4 months)
Devised MedChem strategies for diabetes projects, led research teams based on data generated by several scientific disciplines: - Contributed to clinical candidate selections - Invented novel compound class and successfully secured intellectual property protection
Research Scientist
Hoechst AG, Hoechst Marion Roussel, Aventis

December 1991 - December 2000 (9 years 1 month)
Provided scientific project support in cardiovascular, metabolic and inflammatory disease areas, led research lab and supervised associates: - Conceived and produced novel compounds, among them “Cariporide mesylate” (INN), which was tested in phase III clinical trials - Introduced modern chemical synthesis techniques
Postdoctoral Fellow - Bioorganic Chemistry
Stanford University

March 1990 - September 1991 (1 year 7 months)
Worked in Prof. Paul Wender's research group on antitumor antibiotics (dynemicin analogs)

Education

Universität Hannover / University of Hanover
PhD, Organic Chemistry
1987 - 1989
Universität Hannover / University of Hanover
Dipl.-Chem., Chemistry
1981 - 1987

Additional Info

Groups and Associations
American Chemical Society, German Chemical Society (GDCh), BaytoBio
Honors and Awards
Fellow of the German Research Foundation (DFG, 1990-1991)

Recipient of 1st HOECHST Research Award (1994)

LILLY Candidate Selection Achievement Award (2003)

Patents

1 2 3 4 5 6 Next Last      displaying 1 - 50 of 312 patents (Hide Selected Names)
1. Andreas Gerhard Weichert ( Hamburg, DE ) - Eli Lilly and    2. Andreas Gerhard Weichert ( Hamburg, DE )    3. Andreas Weichert ( Egelsbach, DE ) - Hoeschst    4. Andreas Weichert ( Egelsbach, DE ) - Hoechst Marion Roussel Deutschland    5. Andreas Weichert ( Frankfurt, DE ) - Hoechst    6. Andreas Weichert ( Frankfurt am Main, DE ) - Hoechst    7. Andreas Weichert ( Egelsbach, FR ) - Hoechst    8. Andreas Weichert ( Hamburg, DE ) - Aventis Pharma Deutschland    9. Andreas Weichert ( Egelsback, DE ) - Aventis Pharma Deutschland    10. Andreas Weichert ( Norderstedt, DE ) - Sanofi-aventis Deutschland    11. Andreas Weichert ( Norderstedt, DE ) - Aventis Pharma Deutschland    12. Andreas Weichert ( Hamburg, DE )    13. Andreas Weichert ( Egelsbach, DE )    14. Andreas Weichert ( Egelsbach, DE ) - Hoechst    15. Andreas Weichert ( Egelsbach, DE ) - Aventis Pharma Deutschland    16. Andreas Weichert - 阿文蒂斯藥物德國有限公司    17. Andreas Weichert - 赫徹斯特股份公司    18. Andreas Weichert - 赫彻斯特股份公司    19. Andreas Weichert - Hoechst    20. Andreas Weichert - Hoechst Aktiengesellschaftde    21. Dr Andreas Weichert - Hoechst Aktiengesellschaftde    22. Dr Weichert Andreas ( DE ) - Hoechst    23. Weichert Andreas ( DE ) - Sanofi Aventis Deutschland    24. Weichert Andreas ( DE ) - Aventis Pharma    25. Weichert Andreas ( Frankfurt am Main, DE ) - Hoechst    26. Weichert Andreas - Sanofi-Aventis Deutschland    27. Weichert Andreas - Aventis Pharma Deutschland    28. Weichert Andreas ( DE ) - Aventis Pharma Deutschland    29. Weichert Andreas ( DE ) - Sanofi-Aventis Deutschland    30. Weichert Andreas ( IN ) - Hoechst    31. Weichert Andreas ( DE ) - Hoechst    32. Weichert Andreas - Hoechst    33. Weichert Andreas - Hoechst Agde    34. Weichert Andreas - Aventis Pharma Deutschland Gmbhde    35. Weichert Andreas - Hoechst Aktiengesellschaftde    36. Weichert Andreas Dr ( DE ) - Hoechst Marion Roussel de    37. Weichert Andreas Dr ( DE ) - Hoechst    38. Weichert Andreas Dr - Sanofi-Aventis Deutschland    39. Weichert Andreas Dr - Hoechst Marion Roussel Deutsche    40. Weichert Andreas Dr - Hoechst    41. Weichert Andreas Dr - Hoechst Aktiengesellschaftde    42. Weichert Andreas Dr - Aventis Pharma Deutschland Gmbhde    43. Weichert Andreas Gerhard ( DE ) - Lilly Co Eli    44. Weichert Andreas Gerhard ( DE ) - Eli Lilly And    45. 威契特 ANDREAS WEICHERT - 阿凡提斯藥品德意志有限公司 Aventis Pharma Deutschland 德國    46. 安卓威屈爾 ANDREAS WEICHERT - 阿凡提斯藥品德意志有限公司 Aventis Pharma Deutschland 德國    47. 魏安卓 ANDREAS WEICHERT - 阿凡提斯藥品德意志有限公司 Aventis Pharma Deutschland 德國    48. 魏安德 ANDREAS WEICHERT - Hoechst    49. 魏安迪 ANDREAS WEICHERT - Hoechst   


Enter name of products using these patents, separated by comma.

Select All     Unselect All     Link Products     Toggle Notes    
2012
2009
2008
2007
2006
2005
2004
2003

1 2 3 4 5 6 Next Last     

Connections (157)

Andrea Zaliani
at Nycomed Pharma / Apontis GmbH
Konstanz Area, Germany | Pharmaceuticals
+49 7531 3623714 (home)
Skype Me(TM)!
Edward Zartler
Research Fellow at Merck
Greater Philadelphia Area | Pharmaceuticals
215-756-6816 (mobile)
Skype Me(TM)!
Saradhi Bolli
Sr. Manager - Business Development & Project Management at Neuland Laboratories Limited
Hyderabad Area, India | Pharmaceuticals
+919966030784 (mobile)
Skype Me(TM)!
Sigrid Viergutz
Senior Director, Head of International R&D Outsourcing at Nycomed
Copenhagen Area, Denmark | Pharmaceuticals
+45 3036 8640 (mobile)
Skype Me(TM)!

View all 157 connections

Comments

Michael Lin 林立 , 27 Jan, 2012  

Dear Dr. Weichert,

You are welcome to join in this community to connect and communicate with worldwide Inventors.

If you find this service is useful, please remember to invite your connections and update your profile regularly.

Cheers,

Michael Lin

This comment is useful 1    This comment is not useful 0